PCR.WA
PCC Rokita SA
Price:  
75.3 
PLN
Volume:  
1,164
Poland | Chemicals

PCR.WA WACC - Weighted Average Cost of Capital

The WACC of PCC Rokita SA (PCR.WA) is 10.1%.

The Cost of Equity of PCC Rokita SA (PCR.WA) is 12.3%.
The Cost of Debt of PCC Rokita SA (PCR.WA) is 5.8%.

RangeSelected
Cost of equity10.2% - 14.4%12.3%
Tax rate13.1% - 15.6%14.35%
Cost of debt4.9% - 6.7%5.8%
WACC8.4% - 11.8%10.1%
WACC

PCR.WA WACC calculation

CategoryLowHigh
Long-term bond rate5.5%6.0%
Equity market risk premium6.3%7.3%
Adjusted beta0.741.07
Additional risk adjustments0.0%0.5%
Cost of equity10.2%14.4%
Tax rate13.1%15.6%
Debt/Equity ratio
0.430.43
Cost of debt4.9%6.7%
After-tax WACC8.4%11.8%
Selected WACC10.1%

PCR.WA's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for PCR.WA:

cost_of_equity (12.30%) = risk_free_rate (5.75%) + equity_risk_premium (6.80%) * adjusted_beta (0.74) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.